CYP24A1
Basic information
Region (hg38): 20:54153446-54173986
Previous symbols: [ "CYP24" ]
Links
Phenotypes
GenCC
Source:
- autosomal recessive infantile hypercalcemia (Supportive), mode of inheritance: AR
- hypercalcemia, infantile, 1 (Strong), mode of inheritance: AR
- hypercalcemia, infantile, 1 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hypercalcemia, infantile 1 | AR | Endocrine; Renal | Individuals may present early in life with typical hypercalcemic signs/symptoms (eg, failure to thrive,dehydration, and muscular hypotonia or lethargy), or may present later with nephrolithiasis and nephrocalcinosis, and dietary measures, including avoidance of certain vitamin supplements (eg, vitamin D-containing compounds) to avoid hypercalcemia can be beneficial | Endocrine; Renal | 3490596; 21675912; 22047572; 23293122 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (13 variants)
- Hypercalcemia, infantile, 1 (8 variants)
- Ataxia-telangiectasia syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP24A1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 24 | 32 | ||||
missense | 86 | 104 | ||||
nonsense | 7 | |||||
start loss | 0 | |||||
frameshift | 11 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 3 | 4 | 1 | 8 | ||
non coding | 32 | 27 | 50 | 109 | ||
Total | 18 | 13 | 123 | 58 | 59 |
Highest pathogenic variant AF is 0.000145
Variants in CYP24A1
This is a list of pathogenic ClinVar variants found in the CYP24A1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-54153484-T-C | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 13, 2018) | ||
20-54153515-C-CAT | Infantile hypercalcemia | Benign (Jun 14, 2016) | ||
20-54153637-G-A | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 12, 2018) | ||
20-54153650-T-G | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 12, 2018) | ||
20-54153677-G-C | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 13, 2018) | ||
20-54153681-G-A | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 13, 2018) | ||
20-54153758-G-A | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 13, 2018) | ||
20-54153785-A-G | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 13, 2018) | ||
20-54153887-A-C | Hypercalcemia, infantile, 1 | Benign (Jan 13, 2018) | ||
20-54153900-G-A | Hypercalcemia, infantile, 1 | Benign (Jan 13, 2018) | ||
20-54153934-A-C | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 12, 2018) | ||
20-54154024-C-T | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 13, 2018) | ||
20-54154056-C-T | Hypercalcemia, infantile, 1 | Benign (Jan 13, 2018) | ||
20-54154057-G-C | Hypercalcemia, infantile, 1 | Benign (Jan 13, 2018) | ||
20-54154058-GAC-G | Infantile hypercalcemia | Uncertain significance (Jun 14, 2016) | ||
20-54154072-G-GAC | Infantile hypercalcemia | Uncertain significance (Jun 14, 2016) | ||
20-54154223-T-A | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 12, 2018) | ||
20-54154247-G-A | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 13, 2018) | ||
20-54154254-T-C | Infantile hypercalcemia | Uncertain significance (Jun 14, 2016) | ||
20-54154318-C-T | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 13, 2018) | ||
20-54154334-G-A | Hypercalcemia, infantile, 1 | Benign (Jan 13, 2018) | ||
20-54154397-T-C | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 12, 2018) | ||
20-54154455-A-G | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 13, 2018) | ||
20-54154528-G-A | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 12, 2018) | ||
20-54154555-T-C | Hypercalcemia, infantile, 1 | Uncertain significance (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYP24A1 | protein_coding | protein_coding | ENST00000216862 | 11 | 20525 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.20e-23 | 0.000142 | 125628 | 0 | 120 | 125748 | 0.000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.10 | 332 | 280 | 1.19 | 0.0000156 | 3345 |
Missense in Polyphen | 145 | 121.48 | 1.1936 | 1411 | ||
Synonymous | -0.969 | 123 | 110 | 1.12 | 0.00000608 | 973 |
Loss of Function | -0.729 | 32 | 27.9 | 1.15 | 0.00000138 | 329 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000926 | 0.000926 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00154 | 0.00152 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000475 | 0.000466 |
Middle Eastern | 0.00154 | 0.00152 |
South Asian | 0.000265 | 0.000261 |
Other | 0.000826 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Has a role in maintaining calcium homeostasis. Catalyzes the adrenodoxin-dependent 24-hydroxylation of calcidiol (25- hydroxyvitamin D(3)) and calcitriol (1-alpha,25-dihydroxyvitamin D(3)). The enzyme can perform up to 6 rounds of hydroxylation of calcitriol leading to calcitroic acid. It also shows 23- hydroxylating activity leading to 1-alpha,25-dihydroxyvitamin D(3)-26,23-lactone as end product. {ECO:0000269|PubMed:15574355}.;
- Disease
- DISEASE: Hypercalcemia, infantile, 1 (HCINF1) [MIM:143880]: A disorder characterized by abnormally high level of calcium in the blood, failure to thrive, vomiting, dehydration, and nephrocalcinosis. {ECO:0000269|PubMed:21675912}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Steroid biosynthesis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Vitamin D Metabolism;Vitamin D Receptor Pathway;Nuclear Receptors in Lipid Metabolism and Toxicity;PI3K-AKT-mTOR - VitD3 Signalling;Oxidation by Cytochrome P450;Metapathway biotransformation Phase I and II;Phase I - Functionalization of compounds;Metabolism of lipids;Vitamins;Cytochrome P450 - arranged by substrate type;Biological oxidations;Metabolism;Metabolism of steroids;Vitamin D3 (cholecalciferol) metabolism;Vitamin D (calciferol) metabolism;Steroid hormones
(Consensus)
Recessive Scores
- pRec
- 0.424
Intolerance Scores
- loftool
- 0.973
- rvis_EVS
- 0.02
- rvis_percentile_EVS
- 55.76
Haploinsufficiency Scores
- pHI
- 0.0881
- hipred
- N
- hipred_score
- 0.419
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.219
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cyp24a1
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; renal/urinary system phenotype; skeleton phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- osteoblast differentiation;vitamin metabolic process;response to vitamin D;vitamin D metabolic process;vitamin D catabolic process;oxidation-reduction process;vitamin D receptor signaling pathway
- Cellular component
- nucleus;nucleoplasm;mitochondrion;mitochondrial outer membrane;plasma membrane
- Molecular function
- iron ion binding;25-hydroxycholecalciferol-24-hydroxylase activity;oxidoreductase activity;heme binding;1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity